An observational study in Postoperative Complications, Thoracic Surgery and Perioperative Monitoring, sponsored by Tongji Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.
Sponsored by Tongji Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 159 studies in Postoperative Complications with a site in China — 47 open to participants now, 54 under way, none of them phase 3. Postoperative Complications · China.
Among the 159 studies in Postoperative Complications with a site in China, this one is the 24th largest by planned enrollment of the 63 observational ones that give a count, is one of 8 that started in 2025, is one of 63 observational ones, reaches primary completion later than 27 of the 53 other live ones, and was the 149th registered.
1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.
Browse Postoperative Complications studies →47 of the 159 studies in Postoperative Complications with a site in China are open now. Recruiting first, the newest first:
Beijing Tsinghua Chang Gung Hospital · Sites in China
Ages 18+
Sir Run Run Shaw Hospital · Sites in China
Ages 18+
Fudan University · Sites in China
Ages 18–80
Qun Zhao · Sites in China
Ages 18–85
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Sites in China
Ages up to 18
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
159 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 6 · Phase 3 3 · Phase 4 15
First in 2005; this study’s year is marked. 8 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 650 is above the median of 251 across 541 observational studies indexed under Postoperative Complications.
Median enrollment 205 across the 96 interventional studies, 472 across the 63 observational. Of the 69 that completed or were terminated, 3 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 159 have an industry lead sponsor. The 10 most frequent:
Tongji Hospital is the lead sponsor of 392 studies on the registry; 213 are open to participants now.
Tongji Hospital has 3 studies filed under Postoperative Complications — fewer than ten, so there is no comparison to draw.
15 of the studies in Postoperative Complications with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07646730Tongji HospitalWearable Device-Based Early Warning of Postoperative Complications in Thoracic Surgery | 2026-11-30 |
| NCT04209218Peking University First HospitalIntraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery | 2026-12 |
| NCT03116490Wenzhou Medical UniversityThe Effects of Anesthesia Type on the Prognosis of Hip Fracture Surgery on Elderly Patients | 2026-12 |
| NCT07761390ZhulilingDIEP-MDS for Risk Stratification of Flap Vascular Compromise and Failure in Breast Reconstruction | 2026-12-31 |
| NCT07335042Beijing Tsinghua Chang Gung HospitalPrediction Model for MINS After Major Hepatobiliary Surgery | 2026-12-31 |
Add all 15 to your calendar (.ics) → With an account.
Among the 159 studies in Postoperative Complications with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
After thoracic surgery, some patients may develop complications such as lung infection, abnormal heart rhythm, fluid around the lung, prolonged air leak, wound infection, emergency department visits, or hospital readmission. These problems may not be found early if monitoring is only done during routine vital sign checks or follow-up visits.
This study will evaluate whether data collected by a wearable device can help identify early warning signs of postoperative complications in patients undergoing thoracic surgery. The wearable device will collect information such as heart rate, oxygen level, skin temperature, physical activity, sleep, and wearing status.
The study includes two parts. First, the researchers will review previously collected wearable device and medical record data to develop an early warning model. Second, new patients undergoing thoracic surgery will wear the device from hospital admission until about 30 days after discharge. The model will then be tested to see how well it predicts complications that require medical intervention within 30 days after surgery.
The main goal is to evaluate how accurately the wearable device-based model can identify patients who develop postoperative complications and how early the model can provide a warning before the complication is clinically confirmed.
Postoperative complications are an important concern after thoracic surgery. Conventional perioperative monitoring mainly relies on intermittent vital sign measurements, nursing assessments, physician rounds, and routine post-discharge follow-up. This approach may miss short-lasting, nighttime, or activity-related physiological changes that occur before a complication becomes clinically apparent.
Wearable devices can continuously collect physiological and behavioral information, including heart rate, oxygen saturation, skin temperature, activity, sleep, and wearing status. Combining these data with electronic medical record information may help identify early changes associated with postoperative complications.
This study uses a retrospective and prospective cohort design. In the retrospective stage, previously collected wearable device data and electronic medical record data from thoracic surgery patients will be analyzed. The researchers will evaluate the agreement between wearable device measurements and routine clinical vital signs, describe physiological signal patterns before postoperative complications, and develop a preliminary early warning model.
In the prospective validation stage, newly enrolled patients scheduled for thoracic surgery will wear the study wearable device from hospital admission to approximately 30 days after discharge. The early warning model developed from the retrospective data will be applied prospectively using predefined parameters. Model-generated warnings will be recorded. The occurrence of postoperative complications will be verified through inpatient medical records and follow-up after discharge.
The primary reference outcome is postoperative complications requiring medical intervention within 30 days after surgery. These complications may include pulmonary infection, pleural effusion requiring treatment, prolonged air leak, wound infection, postoperative arrhythmia, emergency department visit, or readmission. Model performance will be evaluated using sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and warning lead time. Wearable device adherence, data completeness, and the added predictive value of wearable device-derived features beyond routine clinical variables will also be assessed.
The study population includes adult patients aged 18 years or older who are hospitalized in the Department of Thoracic Surgery of Tongji Hospital and are scheduled to undergo thoracic surgery. Eligible patients should be able to wear the study-designated wearable device after hospital admission and are expected to continue wearing the device and/or uploading data within 30 days after discharge.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients who previously underwent thoracic surgery and had available wearable device data and electronic medical record data during the perioperative period. This cohort will be used to evaluate agreement between wearable device measurements and routine clinical vital signs, analyze physiological signal trajectories before postoperative complications, and develop a preliminary early warning model.
Device: Wearable device-based perioperative monitoring
Newly enrolled patients scheduled for thoracic surgery who will wear the study wearable device from hospital admission to approximately 30 days after discharge. This cohort will be used to prospectively validate the wearable device-based early warning model for postoperative complications within 30 days after surgery.
Device: Wearable device-based perioperative monitoring
Participants will wear a study wearable device that continuously collects physiological and behavioral data, including heart rate, oxygen saturation, skin temperature, activity, sleep, and wearing status, from hospital admission to approximately 30 days after discharge. The device is used for monitoring and data collection and does not change routine clinical care.
Area under the receiver operating characteristic curve of the wearable device-based early warning model for 30-day postoperative complications
The area under the receiver operating characteristic curve will be used to evaluate the ability of the wearable device-based early warning model to distinguish participants who develop postoperative complications requiring medical intervention within 30 days after surgery from those who do not. Postoperative complications may include pulmonary infection, pleural effusion requiring treatment, prolonged air leak, wound infection, postoperative arrhythmia, emergency department visit, or hospital readmission.
Time frame: From the day of surgery to 30 days after surgery
Warning lead time before clinically confirmed postoperative complications
Warning lead time will be defined as the time interval between the first model-generated warning signal and the clinical confirmation of a postoperative complication requiring medical intervention.
Time frame: From the day of surgery to 30 days after surgery
Sensitivity of the wearable device-based early warning model for 30-day postoperative complications
Sensitivity will be defined as the proportion of participants with postoperative complications requiring medical intervention within 30 days after surgery who are correctly identified by the wearable device-based early warning model.
Time frame: From the day of surgery to 30 days after surgery
Specificity of the wearable device-based early warning model for 30-day postoperative complications
Specificity will be defined as the proportion of participants without postoperative complications requiring medical intervention within 30 days after surgery who are correctly classified as not having a warning signal by the wearable device-based early warning model.
Time frame: From the day of surgery to 30 days after surgery
Plan to share: No — No individual participant data will be shared because the study data include wearable device monitoring data and clinical information from electronic medical records, which may contain sensitive health information. Only aggregate results will be reported.
No publications or documents are linked to this record.
Started Dec 2025 (actual). Primary completion is estimated for Nov 2026, 11 months after the start.
Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 11 months is below that.
Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.